About
Claudia Gravekamp, Ph.D., is an Associate Professor in the Department of Microbiology & Immunology at Albert Einstein College of Medicine whose work centers on cancer immunotherapy, Listeria-based vaccine platforms, and age-related changes in vaccine response. Her published and institutional profile emphasizes preclinical development of therapies for metastatic breast and pancreatic cancer, including work supported by the Paul F. Glenn Center for the Biology of Human Aging. She also holds ecosystem roles as a scientific advisor and biotech co-founder associated with companies such as Matter Bio, Manhattan BioSolutions, Loki Therapeutics, and Regenova Pharmaceuticals.
Areas of interest
aging biologylongevitycancer immunotherapyoncologybacterial therapeuticsvaccinestumor immunologypancreatic cancermetastatic breast cancergenome integrity